Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2020-2026

Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.
Market Analysis and Insights: Global Infectious Disease Point of Care Diagnostics Market
In 2019, the global Infectious Disease Point of Care Diagnostics market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Infectious Disease Point of Care Diagnostics Scope and Market Size
Infectious Disease Point of Care Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Point of Care Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Infectious Disease Point of Care Diagnostics market is segmented into Over-the-counter (OTC) Testing Kits, Prescription-based Testing Kits, etc.
Segment by Application, the Infectious Disease Point of Care Diagnostics market is segmented into Bacterial Infections, Fungal Infection, Virus Infection, Cardiovascular Infection, Gastrointestinal Infection, Sexually Transmitted Disease (STD) Infection, Central Nervous System Infection, Other, etc.
Regional and Country-level Analysis
The Infectious Disease Point of Care Diagnostics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Infectious Disease Point of Care Diagnostics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Infectious Disease Point of Care Diagnostics Market Share Analysis
Infectious Disease Point of Care Diagnostics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Infectious Disease Point of Care Diagnostics business, the date to enter into the Infectious Disease Point of Care Diagnostics market, Infectious Disease Point of Care Diagnostics product introduction, recent developments, etc.
The major vendors include Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, etc.

This report focuses on the global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International

Market segment by Type, the product can be split into

Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits

Market segment by Application, split into

Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Infectious Disease Point of Care Diagnostics are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.